PPARA and Alzheimer disease: Bezafibrate, a PPAR pan-agonist, has been shown to rescue mitochondrial dysfunction and to significantly improve cognitive/memory function in AD mice accompanied by the alleviation of amyloid pathology and neuronal loss as well as reduced oxidative stress and neuroinflammation [195].